Pricing a COVID-19 Vaccine
A recent episode of NPR's INDICATOR offers a look at the issue of pricing a vaccine for COVID-19. The episode [...]
How is COVID-19 Impacting RWD-Based Initiatives in Oncology?
A recent OncLive article looks at how the COVID-19 pandemic is shaping real-world data initiatives in the oncology landscape. The [...]
Proposed Medicaid Changes Aim to Foster Innovative Contracts
The Centers for Medicare and Medicaid Services (CMS) is hoping to encourage greater use of innovative contracting models in a [...]
Cytel Outlines Use of Bayesian Methodologies
A new white paper from Cytel outlines how its statisticians have used Bayesian methodologies in the search for effective COVID-19 [...]
IQVIA Offering On-Demand Webinar on RWE
IQVIA is offering on-demand access to its recent web event on real-world evidence. The webinar was hosted in partnership with [...]
CSRxP’s Aronson: Pharma Must Halt Summer Price Hikes
The Campaign for Sustainable Rx Pricing (CSRxP) is calling on the pharmaceutical industry to halt summer price hikes as the [...]
Article Highlights Causes, Potential Solutions for High Drug Prices
While there are "no easy solutions" to high drug prices, there are a number of steps that could help wrangle [...]
ISPOR Plans Educational Webinar for Members
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is set to host a webinar aimed at helping members bolster [...]
ICER to Assess Roxadustat for Treatment Anemia in Chronic Kidney Disease
The Institute for Clinical and Economic Review (ICER) announced plans to assess FibroGen's roxadustat for the treatment of anemia in [...]
ISPOR Offers Short Courses on Medical Devices, Payment Models
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is offering short courses on medical devices and different payment models [...]
PBMs Report Ease in Demand for Hydroxychloroquine
Pharmacy benefit managers last month reported an easing of demand for the antimalarial drug hydroxychloroquine following a rapid surge spurred [...]
Valid Insight Report Explores Insights from Roundtable on Payer Engagement
A new report from Valid Insight explores key insights generated from a roundtable discussion on payer engagement. The white paper, [...]
Podcast Highlights ‘Buy and Bill’ Model in Oncology
Memorial Sloan Kettering Cancer Center's Dr. Aaron Mitchell in the latest Relentless Health Value podcast discusses the "buy and bill" [...]
OptumRx: Rising Orphan Drug Competition Could Lead to Lower Prices
Increased competition in the orphan drug market could ultimately help pull down prices, OptumRx suggests in a new report. According [...]
ACR Tapped as Imaging Partner for COVID-19 Registry
The Society of Clinical Care Medicine (SCCM) has chosen the American College of Radiology (ACR) to be the main imaging [...]
Report: HEOR Services Market Poised for Rapid Growth
The health economics and outcomes research (HEOR) services market is set to see "rapid growth" between 2020-2025, according to a [...]
NPC: ‘Ready, aim, fire’ Mentality Detrimental in Health Care
Having a "ready, aim, fire" mentality can prove harmful when sharing health care information, the National Pharmaceutical Council (NPC) writes [...]
Legislation Aims to Prevent Pharma From Price-gouging During Pandemic
Two new bipartisan bills introduced by House Democrats aim to prevent the pharmaceutical industry from engaging in price-gouging on COVID-19 [...]
Report Reveals Racial Disparities in COVID-19 Outcomes
New data released by the government on Monday suggests black Americans under Medicare were roughly four times more likely as [...]
‘Domestic Reference Pricing’ for COVID-19 Drugs?
While the Trump administration has in the past proposed international reference pricing for drug pricing in the U.S., a Health [...]
NPC Plans Webinar in Prices for COVID-19 Drugs
An upcoming webinar hosted by the National Pharmaceutical Council (NPC) will discuss a range of pricing-related issues for COVID-19 drugs. [...]
Hahn: Some COVID-19 Changes to Remain
Food and Drug Administration (FDA) Chief Stephen Hahn recently said some changes made to address COVID-19 will remain in place, [...]
Informa Pharma Intelligence Plans 24-Hour Webinar Series
Informa Pharma Intelligence is set to host a free, 24-hour interactive webinar series on the latest insights into COVID-19. The [...]
Blog Post Explores Novel Value Elements for Assessment of COVID-19 Drugs
A recent Health Affairs blog post suggests the inclusion of more novel value elements in the assessment of COVID-19 drugs [...]
ISPOR-FDA Summit Transitions to Virtual Event
The International Society for Pharmacoeconomics and Outcomes Research's (ISPOR) announced that the joint ISPOR-FDA Summit 2020, set for Sept. 29, [...]